FDA: Expand Use of Real-World Evidence in Drug Approvals

New information technology gives the U.S. an opportunity to accelerate the development, review, and approval of new medicines. This can be done through greater use of real-world data (RWD) and real-world evidence (RWE) rather than through the results of expensive clinical trials alone. Recent nominees for senior Department of Health and Human Services (HHS) leadership […]